Emergent accuses biotech execs of wrecking pact
Rockville, MD-based Emergent BioSolutions has filed suit against Protein Sciences, saying the vaccine developer never planned to follow through on a planned $75 million acquisition agreement. According to Emergent's claim, the top executives of Protein Sciences ridiculed the deal after it was announced and only really wanted $10 million in bridge financing that came with the pact so it could pursue other options. Protein Sciences' Daniel D. Adams and Manon M.J. Cox were singled out in the lawsuit.
- read the report in FierceVaccines
- here's the Washington Post article
Related Articles:
Emergent adds new space for biotech start-ups
Emergent buys Protein Sciences in $75M deal
Emergent BioSolutions files $86M IPO
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
